Recombinant Anti-CD7 x Anti-saporin Bispecific Antibody (Diabody-CH3) (BSDBC-130)

Recombinant Anti-CD7 x Anti-saporin Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-CD7 and anti-saporin antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can be used in pretargeting system and deliver immunotoxin to tumor cells. It is designed for the research of Multiple myeloma (MM); Hematologic malignancies therapy.

Datasheet INQUIRY

Specifications

Targets

CD7 & saporin

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Pretargeting system for immunotoxin delivery

Related Disease

Multiple myeloma (MM); Hematologic malignancies

Targets

Target 1

CD7

Gene ID

924

UniProt ID

P09564

Alternative Names

CD7 molecule; Cluster of differentiation 7; CD7; GP40; TP41; Tp40; LEU-9

Target 2

saporin

Alternative Names

Saporin; Ribosome inactivating protein; RIP

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD7 x Anti-saporin Bispecific Antibody (Diabody-CH3) (BSDBC-130). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD7 x Anti-saporin Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-130)

Specifications

Targets

Customer Reviews and Q&As